The life sciences and food and beverage consulting firm CRB has named Mike Dieterich as its senior director of sustainability. Dieterich has more than 17 years of experience working in energy and sustainability. He’s led sustainability initiatives at companies such as AstraZeneca where he served as director, U.S. sustainability from January 2018 to April 2023.…
Why digital technologies are seeing lift-off in pharma
The pharma industry has been slower to adopt digital technologies than other less-regulated sectors. But many pharmaceutical companies making aggressive digital investments are beginning to see a payoff. Though comprehensive digital-based programs can cost roughly $50 million to $100 million annually for two to three years, according to McKinsey, they can lead to improved quality, increased…
How Target Value Delivery can help keep pharma construction projects on track
New plant construction in the pharmaceutical industry frequently exceeds the allocated budget and runs over the expected time, contributing to the industry’s challenge to increase drug output over the past decade. Consulting firm Turner & Townsend estimates that some 70% of pharma construction projects miss their original budget by about 15%. Though the pandemic’s impact on…
A brief guide to Pharma 4.0 adoption
Pharma 4.0 projects may have gotten off to a slow start, but they have ramped up recently. Big Pharma has led the charge in deploying Pharma 4.0 projects, which involve the use of digital technology to draw operational efficiency. “It makes sense because a lot of these digital technologies have a big dollar sign with…
CRB names new general counsel
Kansas City, Missouri–based CRB has appointed Courtney Holt as general counsel. The company provides engineering, construction, consulting and architecture services to the life sciences and food and beverage industries. Holt will replace Jim Scott, who will retire later this year. Holt first began working for CRB in 2018 as assistant general counsel. In her role…
Pharma and biotech companies set their sites on sustainability
Sustainability continues to be a hot topic, and the pharmaceutical industry faces pressure to reduce its carbon footprint. As a result, a growing number of pharma companies are stepping up sustainability efforts. In a growing number of locations, pharma companies are seeing drivers in the regulatory environment to force them to prioritize sustainability. “We’re seeing…